Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Gritstone bio logo — A lean biotech company aiming to develop revolutionary immun...

Gritstone bio

A lean biotech company aiming to develop revolutionary immune-based treatment for various cancers.

Founded 2015 United States Emeryville, United States 33 employees Post-IPO Equity Total: $604.10M Biotechnology, Health Care +1

General Information

Company Name Gritstone bio
Founded Year 2015
Location United States Emeryville, United States
Founders / Decision Makers
Team member
Employees 33
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post-IPO Equity
Business Model B2B, B2D
Revenue Model Licensing, Performance Based, Consulting Fee
Social

BounceWatch is an independent company data service, not affiliated with Gritstone bio. To contact Gritstone bio, visit gritstonebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Gritstone bio compare?

A PDF of Gritstone bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Gritstone bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Gritstone bio

Gritstone bio, founded in 2015 and headquartered in the United States, positions itself as a pioneering force within the Biotechnology, Health Care, and Health and Wellness industries. With its slogan, "A lean biotech company aiming to develop revolutionary immune-based treatment for various cancers," the company emphasizes its innovative approach in immuno-oncology and infectious disease treatment.

Backed by a team of distinguished scientific founders and advisors, Gritstone bio aims to redefine cancer and infectious disease therapies by harnessing the immune system’s ability to target diseased cells. Initially focusing on tumor-specific neoantigens, the company has expanded to include viral antigens, potentially broadening its therapeutic horizon significantly.

Following a recent $32.50M Post-IPO Equity investment in April 2024, Gritstone bio is poised to advance its next-generation vaccine development, offering a promising avenue for investors seeking to contribute to transformative healthcare solutions.

Business keywords: Immuno-oncology, Neoantigens, Viral Antigens, Cancer Immunotherapy, Personalized Medicine, Checkpoint Inhibitors, Cancer Vaccines, Infectious Diseases, Epitope Discovery, T Cell Activation, Translational Medicine, Drug Development, Immunotherapy

Services & Products

Development of immunotherapies
Consulting in scientific direction
Operational support in biotech innovation

Target Customers

Cancer patients Healthcare providers Biotech investors Biotech researchers

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $32.50M -
01 Apr 2024
Post IPO Debt $80.00M 2
Hercules Capital
Hercules Capital, Silicon Valley Bank
22 Jul 2022
Post IPO Equity $55.00M 3
Frazier Healthcare Partners Redmile Group Gilead Sciences
Frazier Healthcare Partners, Redmile Group +1
16 Sep 2021
Grant $20.60M 1
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations
17 Aug 2021
Post IPO Equity $125.00M 5
Versant Ventures Redmile Group EcoR1 Capital
Versant Ventures, Redmile Group +3
28 Dec 2020
Post IPO Equity $75.00M -
01 Oct 2019
Series C $21.00M 1
Redmile Group
Redmile Group
01 Jun 2018
Venture Round Undisclosed 1
Bay City Capital
Bay City Capital
01 Oct 2017
Series B $93.00M 9
GV Lilly Asia Ventures Frazier Healthcare Partners
GV, Lilly Asia Ventures +7
07 Sep 2017
Series A $102.00M 7
Casdin Capital Frazier Healthcare Partners The Column Group
Casdin Capital, Frazier Healthcare Partners +5
20 Oct 2015

Gritstone bio Alternatives & Competitors

View All Alternatives
Gritstone bio vs
Agenus
Agenus United States

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehe...

Post-IPO Debt
291 employees
Biotechnology, Health and Wellness
Compare Gritstone bio vs Agenus
Gritstone bio vs
Imugene Limited
Imugene Limited Australia

Bringing Effective New Treatments And Options To Patients Who Need Them

IPO
26 employees
Biotechnology, Health Care
Compare Gritstone bio vs Imugene Limited
Gritstone bio vs
Memgen, Inc.
Memgen, Inc. United States

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

Venture round
7 employees
Biotechnology, Health Care
Compare Gritstone bio vs Memgen, Inc.
Also compare with: Gritstone bio vs Achilles Therapeutics plc Achilles Therapeutics plc View all alternatives

FAQ About Gritstone bio

A lean biotech company aiming to develop revolutionary immune-based treatment for various cancers.
Gritstone bio was founded in 2015.
Gritstone bio is headquartered in Emeryville, United States.
Gritstone bio operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Immuno-oncology, Neoantigens, Viral Antigens and Cancer Immunotherapy. Its customers include Cancer patients, Healthcare providers and Biotech investors.
Gritstone bio has a B2B and B2D business model. Its revenue comes from Licensing, Performance Based and Consulting Fee.
Gritstone bio has approximately 33 employees.
Gritstone bio has completed 10 funding rounds, raising a total of $604.10M. The latest funding stage is Post-IPO Equity.
Gritstone bio offers: Development of immunotherapies, Consulting in scientific direction, Operational support in biotech innovation.
Top alternatives and competitors to Gritstone bio include Agenus, Imugene Limited, Memgen, Inc., Breakpoint Therapeutics, Achilles Therapeutics plc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gritstone bio and Agenus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Gritstone bio, https://bouncewatch.com/company/gritstone-bio, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout